WO1994028129A3 - Tumour metastasis gene - Google Patents

Tumour metastasis gene Download PDF

Info

Publication number
WO1994028129A3
WO1994028129A3 PCT/GB1994/001160 GB9401160W WO9428129A3 WO 1994028129 A3 WO1994028129 A3 WO 1994028129A3 GB 9401160 W GB9401160 W GB 9401160W WO 9428129 A3 WO9428129 A3 WO 9428129A3
Authority
WO
WIPO (PCT)
Prior art keywords
tumour metastasis
metastasis gene
dna fragment
gene
tumour
Prior art date
Application number
PCT/GB1994/001160
Other languages
French (fr)
Other versions
WO1994028129A2 (en
Inventor
David Tarin
Original Assignee
Isis Innovation
David Tarin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation, David Tarin filed Critical Isis Innovation
Priority to CA002149633A priority Critical patent/CA2149633A1/en
Priority to JP7500405A priority patent/JPH09504682A/en
Priority to EP94916320A priority patent/EP0700436A1/en
Priority to AU68022/94A priority patent/AU6802294A/en
Publication of WO1994028129A2 publication Critical patent/WO1994028129A2/en
Publication of WO1994028129A3 publication Critical patent/WO1994028129A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A 2858bp DNA fragment (SEQ ID NO:1) is provided which codes for a protein which is expressed in malignant human tumours and their metastases. The DNA fragment is useful in diagnosing or assessing the prognosis of metastasis of a patient.
PCT/GB1994/001160 1993-05-28 1994-05-27 Tumour metastasis gene WO1994028129A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002149633A CA2149633A1 (en) 1993-05-28 1994-05-27 Tumour metastasis gene
JP7500405A JPH09504682A (en) 1993-05-28 1994-05-27 Tumor metastasis gene
EP94916320A EP0700436A1 (en) 1993-05-28 1994-05-27 Tumour metastasis gene
AU68022/94A AU6802294A (en) 1993-05-28 1994-05-27 Tumour metastasis gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311130A GB9311130D0 (en) 1993-05-28 1993-05-28 Tumor metastasis gene
GB9311130.0 1993-05-28

Publications (2)

Publication Number Publication Date
WO1994028129A2 WO1994028129A2 (en) 1994-12-08
WO1994028129A3 true WO1994028129A3 (en) 1995-02-02

Family

ID=10736338

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1994/001160 WO1994028129A2 (en) 1993-05-28 1994-05-27 Tumour metastasis gene

Country Status (6)

Country Link
EP (1) EP0700436A1 (en)
JP (1) JPH09504682A (en)
AU (1) AU6802294A (en)
CA (1) CA2149633A1 (en)
GB (1) GB9311130D0 (en)
WO (1) WO1994028129A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
WO1997018454A2 (en) * 1995-11-16 1997-05-22 Baylor College Of Medicine Method for identifying metastatic sequences
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
WO1997025443A1 (en) * 1996-01-10 1997-07-17 The University Of Liverpool Metastasis inducing dna's
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
AU734476B2 (en) 1997-11-05 2001-06-14 Baylor College Of Medicine Sequences for targeting metastatic cells
US6545139B1 (en) 1998-03-13 2003-04-08 Baylor College Of Medicine DNA sequence encoding the p99 gene and kits for the detection of neoplasia
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
WO1992000757A1 (en) * 1990-07-09 1992-01-23 Research Corporation Technologies, Inc. Diagnosis of metastatic cancer by the mts-1 gene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064113A (en) * 1973-06-15 1977-12-20 Alelio Gaetano F D Aminophthalic anhydride copolymers
US4131730A (en) * 1975-05-12 1978-12-26 Alelio Gaetano F D Modified polyamic acid from aminophthalic acid anhydride and dianhydride
JPS61143435A (en) * 1984-12-15 1986-07-01 Nitto Electric Ind Co Ltd Moisture-resistant polyimide
JPS6213436A (en) * 1985-07-11 1987-01-22 Nitto Electric Ind Co Ltd Colorless transparent polyimide molding
JPS61226732A (en) * 1985-03-30 1986-10-08 Nitto Electric Ind Co Ltd Liquid crystal display element
KR930005151B1 (en) * 1990-05-15 1993-06-16 재단법인 한국화학연구소 Process for the preparation of polyesther imide imideresin and thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
WO1992000757A1 (en) * 1990-07-09 1992-01-23 Research Corporation Technologies, Inc. Diagnosis of metastatic cancer by the mts-1 gene

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
D. TARIN: "Molecular Genetics of Metastasis", CIBA FOUND. SYMP. ON METASTASIS, vol. 141, 1988, pages 149 - 169 *
J. S. WALLACE ET AL.: "The ras Oncogene and tumor metastasis", DIFFERENTIATION, vol. 41, no. 3, September 1989 (1989-09-01), GERMANY, pages 208 - 215 *
M. CAIRNEY ET AL.: "Secondary Transfer of metastatic capability and confirmation by PCR of concomitant transfer of donor DNA", BRITISH JOURNAL OF CANCER, vol. 62, no. 3, September 1990 (1990-09-01), pages 544 *

Also Published As

Publication number Publication date
GB9311130D0 (en) 1993-07-14
CA2149633A1 (en) 1994-12-08
AU6802294A (en) 1994-12-20
EP0700436A1 (en) 1996-03-13
JPH09504682A (en) 1997-05-13
WO1994028129A2 (en) 1994-12-08

Similar Documents

Publication Publication Date Title
WO1999034004A3 (en) Metastatic breast and colon cancer regulated genes
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
GR3033636T3 (en) Dna sequence and encoded mammary-specific breast cancer protein
AU1316200A (en) Metastatic breast and colon cancer regulated genes
EP1126034A3 (en) Coding sequences of the human BRCA1 gene
EP0871765A4 (en) Determination of cancerous conditions by mage gene expression
GR852940B (en)
MX9503362A (en) Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas.
MX9708791A (en) Ataxia-telangiectasia gene and its genomic organization.
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
DK568587A (en) DNA FRAGMENTS CONTAINING THE ALKALIC CELLULAS GENE, RECOMBINANT PLASMIDS CONTAINING THESE DNA FREGMENTS AND RECOMBINANT MICROORGANISMS
EP0398955A4 (en) Diagnosis of retinoblastoma
WO1994028129A3 (en) Tumour metastasis gene
AU5579096A (en) Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
NZ331300A (en) Recombinant expression of surface-layer (s-layer) proteins
IL93941A0 (en) Retinoblastoma gene product antibodies and their use in cancer prognosis
CA2067797A1 (en) Production and use of human nm23 protein and antibodies therefor
EP0960128A4 (en) Gene product over expressed in cancer cells
FR2709132B1 (en) DNA fragment carrying the gene coding for the fragmentation enzyme N-acetylheparosan and the adjacent sequences allowing its expression, recombinant enzyme and its use.
TW342413B (en) Novel toxins isolated from Bracon Hebetor
WO1996038556A3 (en) Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
WO1999031256A3 (en) Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
DE59914061D1 (en) THE GEN PRV-1 AND ITS USE
MXPA01011563A (en) A novel factor-h related protein 5 and antobodies thereto.
EP1693457A3 (en) Metastatic breast and colon cancer regulated genes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1994916320

Country of ref document: EP

ENP Entry into the national phase

Ref country code: US

Ref document number: 1995 428137

Date of ref document: 19950517

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: CA

Ref document number: 2149633

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2149633

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1994916320

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1994916320

Country of ref document: EP